600216 浙江医药
已收盘 11-13 15:00:00
资讯
新帖
简况
股市必读：浙江医药新发布《浙江医药关于股份回购进展公告》
证券之星 · 11-05
股市必读：浙江医药新发布《浙江医药关于股份回购进展公告》
浙江医药（600216）披露股份回购进展公告，11月03日股价上涨2.33%
证券之星 · 11-03
浙江医药（600216）披露股份回购进展公告，11月03日股价上涨2.33%
浙江医药（600216）2026年三季报简析：净利润同比下降25.76%
证券之星 · 10-30
浙江医药（600216）2026年三季报简析：净利润同比下降25.76%
10月28日浙江医药跌7.71%，泰康均衡优选混合A基金重仓该股
证券之星 · 10-28
10月28日浙江医药跌7.71%，泰康均衡优选混合A基金重仓该股
图解浙江医药三季报：第三季度单季净利润同比下降66.60%
证券之星 · 10-28
图解浙江医药三季报：第三季度单季净利润同比下降66.60%
浙江医药（600216）披露股份回购进展公告，10月15日股价下跌1.72%
证券之星 · 10-15
浙江医药（600216）披露股份回购进展公告，10月15日股价下跌1.72%
股市必读：浙江医药新发布《浙江医药关于股份回购进展公告》
证券之星 · 10-12
股市必读：浙江医药新发布《浙江医药关于股份回购进展公告》
浙江医药（600216）披露股份回购进展公告，10月9日股价上涨0.72%
证券之星 · 10-09
浙江医药（600216）披露股份回购进展公告，10月9日股价上涨0.72%
每周股票复盘：浙江医药（600216）将召开2026年半年度业绩说明会
证券之星 · 09-13
每周股票复盘：浙江医药（600216）将召开2026年半年度业绩说明会
浙江医药新提交“RUUF MEEW”商标注册申请
证券之星 · 09-12
浙江医药新提交“RUUF MEEW”商标注册申请
浙江医药（600216）披露2026年半年度业绩说明会公告，9月8日股价上涨1.41%
证券之星 · 09-08
浙江医药（600216）披露2026年半年度业绩说明会公告，9月8日股价上涨1.41%
每周股票复盘：浙江医药（600216）回购进展显示已购903,100股
证券之星 · 09-06
每周股票复盘：浙江医药（600216）回购进展显示已购903,100股
浙江医药（600216）披露股份回购进展公告，9月1日股价下跌0.39%
证券之星 · 09-01
浙江医药（600216）披露股份回购进展公告，9月1日股价下跌0.39%
每周股票复盘：浙江医药（600216）Q2净利增20.73%
证券之星 · 08-30
每周股票复盘：浙江医药（600216）Q2净利增20.73%
浙江医药（600216）2026年中报简析：增收不增利，三费占比上升明显
证券之星 · 08-27
浙江医药（600216）2026年中报简析：增收不增利，三费占比上升明显
图解浙江医药中报：第二季度单季净利润同比增长20.73%
证券之星 · 08-26
图解浙江医药中报：第二季度单季净利润同比增长20.73%
8月24日浙江医药跌5.14%，天弘医疗健康混合A基金重仓该股
证券之星 · 08-24
8月24日浙江医药跌5.14%，天弘医疗健康混合A基金重仓该股
8月21日浙江医药跌8.88%，天弘医疗健康混合A基金重仓该股
证券之星 · 08-21
8月21日浙江医药跌8.88%，天弘医疗健康混合A基金重仓该股
异动快报：浙江医药（600216）8月12日10点25分触及涨停板
证券之星 · 08-12
异动快报：浙江医药（600216）8月12日10点25分触及涨停板
每周股票复盘：浙江医药（600216）拟回购1-2亿元股份
证券之星 · 07-26
每周股票复盘：浙江医药（600216）拟回购1-2亿元股份
加载更多
公司概况
公司名称：
浙江医药股份有限公司
所属行业：
医药制造业
上市日期：
1999-10-21
主营业务：
浙江医药股份有限公司的主营业务是药品与生命营养品的研发、生产和销售以及药品流通。公司的主要产品是合成维生素E、维生素A、天然维生素E、维生素H(生物素)、维生素D3、辅酶Q10、β-胡萝卜素、斑蝥黄素、叶黄素、番茄红素、医药制造类产品、医药商业。公司在第二十四届世界制药原料中国展（CPHIChina2026）荣获可持续影响力奖“ESG责任企业奖”。
发行价格：
5.16
{"stockData":{"symbol":"600216","market":"SH","secType":"STK","nameCN":"浙江医药","latestPrice":10.51,"timestamp":1794553200000,"preClose":10.71,"halted":0,"volume":9831518,"delay":0,"changeRate":-0.0187,"floatShares":951000000,"shares":961999999,"eps":0.6583,"marketStatus":"已收盘","change":-0.2,"latestTime":"11-13 15:00:00","open":10.72,"high":10.77,"low":10.5,"amount":104000000,"amplitude":0.0252,"askPrice":10.52,"askSize":80,"bidPrice":10.51,"bidSize":1025,"shortable":0,"etf":0,"ttmEps":0.6583,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":10.71,"symbolType":"stock","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":11.78,"lowLimit":9.64,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":961637750,"isCdr":false,"pbRate":0.88,"roa":"--","peRate":15.965365,"roe":"6.14%","epsLYR":0.91,"committee":0.782286,"marketValue":10107000000,"turnoverRate":0.0103,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-16。","floatMarketCap":9999000000},"requestUrl":"/m/hq/s/600216","defaultTab":"news","newsList":[{"id":"2681669550","title":"股市必读：浙江医药新发布《浙江医药关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681669550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681669550?lang=zh_cn&edition=full","pubTime":"2026-11-05 01:08","pubTimestamp":1793812084,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年10月31日，浙江医药已累计回购股份3,376,000股，占总股本0.35%，支付金额39,991,896.50元。公司公告汇总浙江医药关于股份回购进展公告浙江医药于2026年7月14日董事会审议通过以集中竞价交易方式回购股份的议案，回购资金总额为1亿元至2亿元，回购价格不超过17.90元/股，回购期限为2026年7月14日至2027年7月13日，回购股份拟用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500002416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","600216","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680727510","title":"浙江医药（600216）披露股份回购进展公告，11月03日股价上涨2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680727510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680727510?lang=zh_cn&edition=full","pubTime":"2026-11-03 22:15","pubTimestamp":1793715320,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，浙江医药报收于10.97元，较前一交易日上涨2.33%，最新总市值为105.49亿元。该股当日开盘10.71元，最高11.04元，最低10.67元，成交额达1.96亿元，换手率为1.88%。近日，浙江医药发布《关于股份回购进展公告》。本次回购符合相关法律法规及公司回购方案的规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300045224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0191","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679374246","title":"浙江医药（600216）2026年三季报简析：净利润同比下降25.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679374246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679374246?lang=zh_cn&edition=full","pubTime":"2026-10-30 23:56","pubTimestamp":1793375774,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期浙江医药发布2026年三季报。根据财报显示，浙江医药净利润同比下降25.76%。截至本报告期末，公司营业总收入62.46亿元，同比下降6.71%，归母净利润6.93亿元，同比下降25.76%。按单季度数据看，第三季度营业总收入18.6亿元，同比下降21.6%，第三季度归母净利润8678.5万元，同比下降66.6%。本文数据来源于浙江医药2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000059140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678459794","title":"10月28日浙江医药跌7.71%，泰康均衡优选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678459794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678459794?lang=zh_cn&edition=full","pubTime":"2026-10-28 16:31","pubTimestamp":1793176292,"startTime":"0","endTime":"0","summary":"证券之星消息，10月28日浙江医药跌7.71%创60日新低，收盘报10.9元，换手率3.85%，成交量36.61万手，成交额4.02亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为泰康基金的泰康均衡优选混合A。泰康均衡优选混合A目前规模为2.81亿元，最新净值1.5661，较上一交易日下跌1.27%，近一年上涨27.95%。泰康均衡优选混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800036261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0191","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678107777","title":"图解浙江医药三季报：第三季度单季净利润同比下降66.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678107777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678107777?lang=zh_cn&edition=full","pubTime":"2026-10-28 02:57","pubTimestamp":1793127464,"startTime":"0","endTime":"0","summary":"证券之星消息，浙江医药2026年三季报显示，前三季度公司主营收入62.46亿元，同比下降6.71%；归母净利润6.93亿元，同比下降25.76%；扣非净利润6.37亿元，同比下降28.46%；其中2026年第三季度，公司单季度主营收入18.6亿元，同比下降21.6%；单季度归母净利润8678.5万元，同比下降66.6%；单季度扣非净利润7204.34万元，同比下降68.04%；负债率19.4%，投资收益5810.63万元，财务费用9360.7万元，毛利率35.25%。财报数据概要请见下图:本文数据来源于浙江医药2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800003040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675653369","title":"浙江医药（600216）披露股份回购进展公告，10月15日股价下跌1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675653369","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675653369?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:22","pubTimestamp":1792074134,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘，浙江医药报收于11.98元，较前一交易日下跌1.72%，最新总市值为115.2亿元。该股当日开盘12.07元，最高12.14元，最低11.89元，成交额达1.46亿元，换手率为1.28%。近日，浙江医药发布《关于股份回购进展公告》。截至2026年10月15日，公司已累计回购1,644,400股，占总股本0.17%，回购金额为20,865,059.00元，回购价格区间为11.96元/股至13.00元/股。本次回购符合相关规定及既定方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500039439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0028","BK0239","600216","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674453548","title":"股市必读：浙江医药新发布《浙江医药关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674453548","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674453548?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:47","pubTimestamp":1791740830,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年9月30日，浙江医药已累计回购股份1,534,500股，占总股本0.16%，支付金额1953.44万元。公司公告汇总浙江医药关于股份回购进展公告浙江医药于2026年7月14日董事会审议通过以集中竞价方式回购股份的议案，回购资金总额为1亿元至2亿元，价格不超过17.90元/股，期限为2026年7月14日至2027年7月13日，回购股份拟用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600216","BK0191","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674559850","title":"浙江医药（600216）披露股份回购进展公告，10月9日股价上涨0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674559850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674559850?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:18","pubTimestamp":1791555496,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，浙江医药报收于12.59元，较前一交易日上涨0.72%，最新总市值为121.07亿元。该股当日开盘12.48元，最高12.67元，最低12.38元，成交额达1.63亿元，换手率为1.37%。近日，浙江医药发布《关于股份回购进展公告》。截至2026年9月30日，公司已累计回购股份1,534,500股，占公司总股本的0.16%，已支付金额19,534,379.00元，回购最高价为13.00元/股，最低价为12.24元/股。本次回购符合相关法规及公司方案规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0028","BK0239","600216","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667950737","title":"每周股票复盘：浙江医药（600216）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667950737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667950737?lang=zh_cn&edition=full","pubTime":"2026-09-13 01:49","pubTimestamp":1789235351,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，浙江医药报收于12.33元，较上周的12.68元下跌2.76%。本周，浙江医药9月9日盘中最高价报13.04元。本周关注点公司公告汇总：浙江医药将于2026年9月15日召开半年度业绩说明会。公司公告汇总浙江医药关于召开2026年半年度业绩说明会的公告浙江医药股份有限公司将于2026年9月15日10:00-11:00通过上证路演中心以视频直播和网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果和财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0239","BK0188","BK0191","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666904577","title":"浙江医药新提交“RUUF MEEW”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666904577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666904577?lang=zh_cn&edition=full","pubTime":"2026-09-12 07:27","pubTimestamp":1789169236,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日浙江医药股份有限公司新提交“RUUF MEEW”商标注册申请。商标申请详情如下：今年以来浙江医药股份有限公司新申请注册商标26件，截止目前公司共持有注册商标370件，另有28件商标尚在注册申请中。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了2.46亿元，同比减21.39%。通过天眼查大数据分析，浙江医药股份有限公司共对外投资了36家企业，参与招投标项目100次；财产线索方面有商标信息225条，专利信息27条，著作权信息4条；此外企业还拥有行政许可116个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200006588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0191","BK0239","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321103","title":"浙江医药（600216）披露2026年半年度业绩说明会公告，9月8日股价上涨1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665321103?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:05","pubTimestamp":1788861934,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，浙江医药报收于12.95元，较前一交易日上涨1.41%，最新总市值为124.53亿元。该股当日开盘12.72元，最高12.98元，最低12.7元，成交额达2.02亿元，换手率为1.66%。浙江医药当日发布公告称，公司将于2026年9月15日10:00-11:00通过上证路演中心以视频直播和网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果和财务状况。投资者可于2026年9月8日至9月14日16:00前通过上证路演中心网站或公司邮箱board@zmc-china.com提问。说明会后可通过该平台查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0191","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365730","title":"每周股票复盘：浙江医药（600216）回购进展显示已购903,100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365730","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365730?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:30","pubTimestamp":1788633031,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，浙江医药报收于12.68元，较上周的13.19元下跌3.87%。本周，浙江医药8月31日盘中最高价报13.09元。浙江医药当前最新总市值121.94亿元，在化学制药板块市值排名36/149，在两市A股市值排名1515/5214。本周关注点公司公告汇总：回购进展显示已购903,100股，支付金额11,536,865.00元公司公告汇总浙江医药关于股份回购进展公告：截至2026年8月31日，公司累计回购股份903,100股，占总股本的0.09%，已支付金额11,536,865.00元，回购价格区间为12.55元/股至13.00元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600216","BK0239","BK0191","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664411837","title":"浙江医药（600216）披露股份回购进展公告，9月1日股价下跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664411837","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664411837?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:31","pubTimestamp":1788255111,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，浙江医药报收于12.88元，较前一交易日下跌0.39%，最新总市值为123.86亿元。公司于近日披露《浙江医药关于股份回购进展公告》。公告显示，浙江医药股份有限公司于2026年7月14日召开董事会，审议通过以集中竞价交易方式回购股份的议案，回购资金总额为1亿元至2亿元，回购价格不超过17.90元/股，回购期限为2026年7月14日至2027年7月13日，回购股份拟用于员工持股计划或股权激励。本次回购符合相关法规及公司回购方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100030611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0188","BK0239","600216","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010969","title":"每周股票复盘：浙江医药（600216）Q2净利增20.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010969","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010969?lang=zh_cn&edition=full","pubTime":"2026-08-30 02:47","pubTimestamp":1788029229,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，浙江医药报收于13.19元，较上周的13.23元下跌0.3%。本周，浙江医药8月26日盘中最高价报13.35元。本周关注点来自业绩披露要点：2026年第二季度归母净利润同比上升20.73%。来自股本股东变化：截至2026年6月30日股东户数为5.56万户，较上期增加7.26%。户均持股数量由1.86万股下降至1.73万股，户均持股市值为19.72万元。第二季度单季主营收入21.95亿元，同比上升6.18%；单季度归母净利润3.19亿元，同比上升20.73%；单季度扣非净利润2.91亿元，同比上升10.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","BK0188","600216","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740303","title":"浙江医药（600216）2026年中报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740303?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:03","pubTimestamp":1787781802,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期浙江医药发布2026年中报。截至本报告期末，公司营业总收入43.86亿元，同比上升1.46%，归母净利润6.06亿元，同比下降9.99%。本报告期浙江医药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达36.54%。持有浙江医药最多的基金为天弘医疗健康混合A，目前规模为2.15亿元，最新净值1.8044，较上一交易日上涨0.29%，近一年下跌6.15%。本文数据来源于浙江医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0191","BK0188","600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751341","title":"图解浙江医药中报：第二季度单季净利润同比增长20.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751341","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662751341?lang=zh_cn&edition=full","pubTime":"2026-08-26 02:20","pubTimestamp":1787682035,"startTime":"0","endTime":"0","summary":"证券之星消息，浙江医药2026年中报显示，上半年度公司主营收入43.86亿元，同比上升1.46%；归母净利润6.06亿元，同比下降9.99%；扣非净利润5.65亿元，同比下降15.05%；其中2026年第二季度，公司单季度主营收入21.95亿元，同比上升6.18%；单季度归母净利润3.19亿元，同比上升20.73%；单季度扣非净利润2.91亿元，同比上升10.68%；负债率18.48%，投资收益2947.95万元，财务费用6878.6万元，毛利率37.15%。财报数据概要请见下图:本文数据来源于浙江医药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600005127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661138221","title":"8月24日浙江医药跌5.14%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661138221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661138221?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:27","pubTimestamp":1787560031,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日浙江医药跌5.14%，收盘报12.55元，换手率4.12%，成交量39.23万手，成交额5.01亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.15亿元，最新净值1.8229，较上一交易日下跌3.09%，近一年下跌6.15%。天弘医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0188","600216","BK0191","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661655682","title":"8月21日浙江医药跌8.88%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661655682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661655682?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:38","pubTimestamp":1787301510,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日浙江医药跌8.88%，收盘报13.23元，换手率6.52%，成交量62.0万手，成交额8.38亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.15亿元，最新净值1.881，较上一交易日上涨1.84%，近一年下跌6.15%。天弘医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","600216","BK0188","BK0191","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658401709","title":"异动快报：浙江医药（600216）8月12日10点25分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2658401709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658401709?lang=zh_cn&edition=full","pubTime":"2026-08-12 10:30","pubTimestamp":1786501847,"startTime":"0","endTime":"0","summary":"证券之星8月12日盘中消息，10点25分浙江医药（600216）触及涨停板。其所属行业化学制药目前上涨。领涨股为美诺华。该股为维生素，钠电池，化学原料药概念热股，当日维生素概念上涨1.54%，钠电池概念上涨1.18%，化学原料药概念上涨0.54%。8月11日的资金流向数据方面，主力资金净流入729.26万元，占总成交额2.51%，游资资金净流出920.48万元，占总成交额3.17%，散户资金净流入191.22万元，占总成交额0.66%。近5日资金流向一览见下表：浙江医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200012346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600216","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654052252","title":"每周股票复盘：浙江医药（600216）拟回购1-2亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2654052252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654052252?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:47","pubTimestamp":1785001632,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，浙江医药报收于11.63元，较上周的12.09元下跌3.8%。本周，浙江医药7月21日盘中最高价报12.44元。公司公告汇总浙江医药发布以集中竞价交易方式回购股份的报告书，拟回购资金总额不低于1亿元且不超过2亿元，资金来源于自有资金或自筹资金。公司已获得工商银行不超过1.8亿元的股票回购专项贷款承诺。回购股份将用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0191","600216","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794750524982,"stockEarnings":[{"period":"1week","weight":-0.0566},{"period":"1month","weight":-0.1378},{"period":"3month","weight":-0.2116},{"period":"6month","weight":-0.2401},{"period":"1year","weight":-0.2831},{"period":"ytd","weight":-0.2237}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"62381人(较上一季度增加12.22%)","perCapita":"15251股","listingDate":"1999-10-21","address":"浙江省绍兴市越城区滨海新城致远中大道168号","registeredCapital":"96163万元","survey":" 浙江医药股份有限公司的主营业务是药品与生命营养品的研发、生产和销售以及药品流通。公司的主要产品是合成维生素E、维生素A、天然维生素E、维生素H(生物素)、维生素D3、辅酶Q10、β-胡萝卜素、斑蝥黄素、叶黄素、番茄红素、医药制造类产品、医药商业。公司在第二十四届世界制药原料中国展（CPHIChina2026）荣获可持续影响力奖“ESG责任企业奖”。","listedPrice":5.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浙江医药(600216)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浙江医药(600216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浙江医药,600216,浙江医药股票,浙江医药股票老虎,浙江医药股票老虎国际,浙江医药行情,浙江医药股票行情,浙江医药股价,浙江医药股市,浙江医药股票价格,浙江医药股票交易,浙江医药股票购买,浙江医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浙江医药(600216)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浙江医药(600216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}